SMS Pharmaceuticals rises on acquiring 4.9% stake in Provenio Astral International LLP

19 Oct 2022 Evaluate

SMS Pharmaceuticals is currently trading at Rs. 88.00, up by 0.15 points or 0.17% from its previous closing of Rs. 87.85 on the BSE.

The scrip opened at Rs. 87.75 and has touched a high and low of Rs. 88.00 and Rs. 85.00 respectively. So far 3678 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 150.50 on 19-Oct-2021 and a 52 week low of Rs. 71.00 on 17-Jun-2022.

Last one week high and low of the scrip stood at Rs. 91.35 and Rs. 85.00 respectively. The current market cap of the company is Rs. 744.94 crore.

The promoters holding in the company stood at 64.17%, while Institutions and Non-Institutions held 0.63% and 35.20% respectively.

SMS Pharmaceuticals has acquired 4.9% stake by investing Rs 9,80,000 in Provenio Astral International LLP (Formerly Known as Studiom Square LLP).

This strategic partnership may help the company to expand its business in overseas and also If the company wish to establish any facility in overseas in future. This partnership will benefit to procure established connectivity facility with lesser price than the market.

SMS Pharmaceuticals is a global player in API and intermediates manufacturing having a strong research and manufacturing team supported by state?of?the?art facilities.


SMS Pharmaceuticals Share Price

301.25 -1.60 (-0.53%)
23-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 885.00
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×